Literature DB >> 2213656

Analysis of Pneumocystis carinii cyst wall. II. Sugar composition.

J A De Stefano1, M T Cushion, V Puvanesarajah, P D Walzer.   

Abstract

Pneumocystis carinii cysts are capable of resisting host defenses and antimicrobial drugs and are therefore thought to be responsible for relapses of P. carinii pneumonia in AIDS and other immunocompromised patients. The interaction of P. carinii with its host, and other P. carinii, might be mediated by molecules which form the outer surfaces of this organism. Carbohydrates are known to play many roles in cell-cell adhesion, and have been detected on the surface of P. carinii by lectin labeling experiments. In this study P. carinii cyst wall material was obtained from Zymolyase treatment. Alditol acetate derivatives of neutral and amino sugars or trimethylsilyl derivatives of methyl glycosides were prepared from the monosaccharides released from the sample by acid hydrolysis. Analyses were done by a combination of gas chromatography and mass spectrometry. Glucose was found to be the major sugar constituent. Mannose and galactose were present in equal ratios. A lesser amount of N-acetyl-D-glucosamine, and trace amounts of ribose and sialic acid were present in the cyst wall samples analyzed. These sugars may mediate P. carinii-host interaction and play an important protective role by creating a permeability barrier around the cyst.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213656     DOI: 10.1111/j.1550-7408.1990.tb01168.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  15 in total

Review 1.  Yeast killer systems.

Authors:  W Magliani; S Conti; M Gerloni; D Bertolotti; L Polonelli
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Chitinases in Pneumocystis carinii pneumonia.

Authors:  Leah R Villegas; Theodore J Kottom; Andrew H Limper
Journal:  Med Microbiol Immunol       Date:  2012-04-26       Impact factor: 3.402

3.  Characterization of N-Acetylglucosamine Biosynthesis in Pneumocystis species. A New Potential Target for Therapy.

Authors:  Theodore J Kottom; Deanne M Hebrink; Paige E Jenson; Jorge H Ramirez-Prado; Andrew H Limper
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

Review 4.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

5.  Ubiquinone synthesis in mitochondrial and microsomal subcellular fractions of Pneumocystis spp.: differential sensitivities to atovaquone.

Authors:  Mireille Basselin; Shannon M Hunt; Hiam Abdala-Valencia; Edna S Kaneshiro
Journal:  Eukaryot Cell       Date:  2005-08

6.  Identification, characterization, and expression of the BiP endoplasmic reticulum resident chaperonins in Pneumocystis carinii.

Authors:  T T Stedman; G A Buck
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 7.  The lipids of Pneumocystis carinii.

Authors:  E S Kaneshiro
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 8.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 9.  Is Pneumocystis carinii a deep mycosis-like agent?

Authors:  E Dei-Cas; J C Cailliez; F Palluault; E M Aliouat; E Mazars; B Soulez; J Suppin; D Camus
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Sialylglycoconjugates and sialyltransferase activity in the fungus Cryptococcus neoformans.

Authors:  Marcio L Rodrigues; Andrey S S Dobroff; José Nelson dos S S Couceiro; Celuta S Alviano; Roland Schauer; Luiz R Travassos
Journal:  Glycoconj J       Date:  2002-03       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.